Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report Intel FAQ API Sign In →
56 /100
HIGH RISK
Score updated Jul 28, 2026

DTIL — Precision BioSciences, Inc. Dilution Risk Tracker

Track DTIL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DTIL — Get alerts when the score changes →

As of July 28, 2026, Precision BioSciences, Inc. (DTIL) has a DilutionWatch DilutionScore of 56/100, rated HIGH dilution risk. Precision BioSciences, Inc. has a market capitalization of $179.84M, 25.80M shares outstanding, 78 institutional holders tracked. Key dilution vectors include approximately 15 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
40
⚠️ Warrant Exposure
40
🔄Convertible Debt

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
20%
🔁 Convertible Conversion 40%
• Significant convertible debt: 22% potential dilution
• Elevated convertible risk (60/100)
🔔 Track DTIL — Get forecast alerts →

Market Data

Market Cap$179.84M
Shares Outstanding25.80M
Float20.01M
Cash$101.18M
Debt$22.27M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 14.0% shares (2026Q1 vs prior)
78 institutional holders · 17.22M shares
#1 Octagon Capital Advisors LP 2.24M shares
#2 Aberdeen Group plc 2.23M shares
#3 Empery Asset Management, LP 1.97M shares
+ 17 more holders Sign up free to view →

Short Interest

Short Interest2.38M
Days to Cover3.6
% of Float11.9%
FINRA data as of Jul 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2019-12-31
4 INSIDER TRANSACTION 2026-06-05
4 INSIDER TRANSACTION 2026-06-05
4 INSIDER TRANSACTION 2026-06-05
Full SEC filing analysis available with free account

Recent News

No recent news

What This Means for DTIL Shareholders

Precision BioSciences, Inc. (DTIL) has a DilutionScore of 56/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 28, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: DTIL has approximately 15 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for DTIL in real-time, scanning EDGAR every 60 seconds. The DilutionWatch shows real-time score changes for DTIL alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding DTIL's Dilution Risk Factors

Primary Risk Drivers

The most concerning factors for Precision BioSciences, Inc. (DTIL) are Offering Ability and Convertible Note Risk, both scoring at the upper end of the risk spectrum. Offering Ability is particularly significant because it indicates that the company has the capacity to raise capital through equity offerings, which can dilute existing shareholders. The Convertible Note Risk score reflects the potential for debt instruments to convert into equity, increasing the total number of shares outstanding. These mechanisms directly contribute to share dilution by introducing new stock into the market, reducing ownership percentages for current investors.

Factors Currently Not a Concern

Float Risk and Warrant Exposure are currently at low levels, indicating minimal immediate risk from these sources. Float Risk is low because there is no indication of excessive trading volume or large block sales that could impact share price. Warrant Exposure remains manageable due to limited outstanding warrants. A change in either area would raise concerns if new warrants were issued or if the company began trading heavily in the open market, which could signal an upcoming capital raise.

SEC Filings to Watch

Several filings are critical to monitor for signs of increased dilution risk. An S-3 registration statement signals a potential public offering that could introduce large numbers of new shares. A 424B5 filing often accompanies such offerings and details the terms of new securities issued. An 8-K Item 1.01 reports material events, including new equity issuances or convertible debt conversions. Additionally, a 10-Q filing may reveal changes in capital structure or new financing activities that could affect share count and investor dilution.

How Dilution Happens

Dilution occurs when existing shares are reduced in value due to an increase in total shares outstanding. For DTIL, this happens through convertible notes converting into equity, which increases the number of shares available. If the company issues new stock under an offering or converts debt into equity, each of these actions adds more shares to the market, reducing each existing shareholder’s percentage ownership. The process is straightforward: as more shares are created, each share represents a smaller portion of the company's value.

What Would Make This Worse

A significant deterioration in DTIL’s risk profile would occur if the company entered into multiple convertible note agreements or began frequent equity offerings. A major event such as a large-scale capital raise through an S-3 filing, combined with the conversion of high-value convertible notes, could substantially increase share count and dilute existing investors. Additionally, any indication that management is actively pursuing aggressive growth strategies through equity financing would signal worsening conditions for shareholders.

Key Insight

Low scores in the risk scale indicate safer conditions, not worse ones — a key principle in interpreting DTIL’s metrics.

How to Monitor DTIL for Dilution Risk

What This Risk Level Means

For a micro-cap operating company like Precision BioSciences (DTIL), a high dilution risk profile indicates that the firm is likely facing significant pressure to raise capital, which could result in substantial ownership dilution for existing shareholders. At this level, the company’s financial health and future capital structure are under scrutiny. Micro-cap companies often rely on frequent capital raises to fund operations, research, or expansion, making them particularly vulnerable to dilutive financing activities. With a high risk score, DTIL is likely in a precarious position where shareholder value could be eroded through equity issuance, warrant exercises, or convertible note conversions.

What Typically Happens Next

Companies at this profile often proceed with capital-raising mechanisms such as shelf registrations, ATM programs, or convertible note financings. These activities are common in micro-cap firms seeking to extend runway without immediate financial distress. In the case of DTIL, a pattern may include issuing new shares through registered offerings or using warrants and convertible notes to raise funds, which increases the potential for dilution. The timing of these events often aligns with financial milestones or when cash reserves are nearing depletion. Monitoring such companies closely helps identify when these financing activities are likely to occur.

Monitoring Playbook

To effectively track DTIL’s dilution risk, use DilutionWatch to set up alerts for key events like new equity offerings or warrant expirations. Check scores weekly or bi-weekly, especially around earnings releases or SEC filing periods. When thresholds such as Offering Ability or Convertible Note Risk exceed 60/100, review the company’s recent filings and financial statements for signs of capital raising. Use Shelf & ATM Monitor to detect new shelf registrations or ATM programs that may signal upcoming dilutive activity.

Early Warning Signals

Several specific signals can indicate worsening dilution risk. First, a sudden spike in Offering Ability or Convertible Note Risk scores suggests an increased likelihood of equity issuance. Second, the filing of a new shelf registration or ATM program may precede large dilutive offerings. Third, a marked increase in Warrant Exposure or a high number of warrants nearing exercise can indicate upcoming share dilution. These changes should be monitored closely as they often precede material dilution events.

What a Positive Resolution Looks Like

A positive shift in DTIL’s profile would occur if the company secures a significant capital raise that extends its runway, or if convertible notes are converted into equity at favorable terms. Paying down debt or having warrants expire without exercise also improves risk metrics. Additionally, a reduction in Offering Ability and Convertible Note Risk scores—particularly if they drop below 40/100—would indicate a healthier capital structure and less immediate dilution pressure.

Watch For

Any increase in Offering Ability or Convertible Note Risk scores above 60/100, as these often precede new equity issuance events.

Full SEC filing analysis available with free account  →
Track DTIL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DTIL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for DTIL
DTIL FDA Catalyst Timeline & Biotech Grade — BiotechSignsDTIL Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.